Product: | DL-Homocysteine-3,3,4,4-d4 | ||||
---|---|---|---|---|---|
Catalog Number: | D2215 | ||||
CAS Number: | 416845-90-4 | ||||
Synonyms: | 2-Amino-4-mercaptobutyric Acid | ||||
Pricing: |
|
||||
Formula: | HSCD2CD2CH(NH2)COOH | ||||
Enrichment: | 98%D | ||||
Molecular Weight: | 139.21 | ||||
Structure: | |||||
Appearance: | White solid | ||||
Category: | Labeled Amino Acids and Derivatives | ||||
Stability: | Stable under recommended storage conditions. | ||||
Storage: |
KEEP FROZEN. Adequate ventilation. Protect from air. Protect from heat |
||||
Transportation: |
Non-hazardous for transport |
||||
Literature References: |
Selhub, J., Homocysteine metabolism. Annual Review of Nutrition, 1999, 19: 217–246.; Nygård, O; Vollset, SE; Refsum, H; Stensvold, I; Tverdal, A; Nordrehaug, JE; Ueland, M; Kvåle, G., Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA: the Journal of the American Medical Association, 1995, Nov.; 274 (19): 1526–33.; Refsum, H; Nurk, E; Smith, AD; Ueland, PM; Gjesdal, CG; Bjelland, I; Tverdal, A; Tell, GS; Nygård, O; Vollset, SE, The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. The Journal of nutrition, 2006, June; 136 (6 Suppl): 1731S–1740S. |
||||
MSDS: | |||||
Applications: | A labeled non-protein alpha-amino acid. High levels in the blood makes a person more prone to endothelial cell injury, which leads to inflamed blood vessels, atherogenesis, and ischemic injury. A possible risk factor for coronary artery disease. Correlated with the occurrence of blood clots, heart attacks and strokes. Also associated with early pregnancy lost and neural tube defects. |